Marco's Morning Report — Friday, June 12, 2026

A · Top Stories

Iran: Trump cancels strikes, says a peace deal is "approved"

After months of an on-again, off-again ceasefire, Trump called off further U.S. strikes on June 11 and said a deal has been approved at the highest level of Iranian leadership, with a signing — possibly in Europe — expected "within days." The naval blockade stays in place until it's signed. He says the framework includes no Iranian uranium enrichment and U.S. help removing deeply buried nuclear material; Lebanon is pointedly not covered, which Tehran is unhappy about.

Why it matters to you: this is the single biggest swing-factor on energy prices right now. The Strait-of-Hormuz scares have been pushing gas and fuel costs up (including in Puerto Rico); a real de-escalation would take pressure off. It's also the kind of "is the war over?" question your parents and patients will ask.

Talking point: "approved conceptually" is not "signed." Watch for an actual signing announcement before believing the blockade lifts.

Knicks one win from their first title since 1973

New York leads the Finals 3–1 after that 29-point Game 4 comeback (OG Anunoby's tip-in with 1.2 seconds left). Game 5 is Saturday, June 14, in San Antonio — first of three chances to close it out. Wembanyama and the Spurs have to win three straight to survive.

Why it matters to you: you're a New York fan and this is genuinely historic — the Knicks haven't won it all in 53 years. If you're off Saturday night, this is the one to watch.

Talking point: even if they drop Game 5, they get Games 6 and 7 at MSG. The math is heavily in their favor.

B · The Debate

Should Congress fix the Inflation Reduction Act's "pill penalty" on small-molecule drugs?

Why it's live: in May the Supreme Court turned away drugmakers' appeals against Medicare price negotiation, so the industry's fight moved to Capitol Hill. The bipartisan EPIC Act would push the negotiation clock for pills back from 9 years to 13 — matching biologics — and this week patient advocates pushed back hard in print.

For fixing it

The IRA exposes small-molecule pills to price-setting at 9 years versus 13 for injected biologics, and that 4-year gap is steering R&D money away from exactly the cheap, convenient oral drugs older patients can actually take at home. Rep. Greg Murphy, M.D. (R-NC), a practicing physician, introduced the EPIC Act citing a University of Chicago brief by economist Tomas Philipson estimating 188 fewer small-molecule medicines over time; industry surveys show a majority of companies already shifting from pills toward biologics.

Against

Drugmakers lost in court repeatedly, the argument goes, and shouldn't get through lobbying what they couldn't win from judges. Writing in The Hill (June 10), Patients For Affordable Drugs' Merith Basey calls the EPIC Act a multibillion-dollar industry windfall paid for by seniors and taxpayers, noting negotiation has already cut prices on the first ten drugs by ~62% and put real money back in patients' pockets. Delaying it, she argues, just protects monopoly pricing longer.

Where it might land: no scheduled floor vote — the EPIC Act is on the reconciliation "wish list," so the fight is over whether it gets folded into a larger package.

C · On My Radar

Mets edge the Cardinals 5–4 (June 11). Juan Soto's go-ahead homer in the 7th did it; Bo Bichette and Jared Young went deep in the first, and Devin Williams nailed down his 9th save. Francisco Lindor (calf) is doing full baseball activities and is eyed for a return the third week of June. Recap.

Worth queuing this week (critics love them): the final season of Hacks, AMC's The Vampire Lestat, and the Paul McCartney documentary Man on the Run — all sitting high on the Rotten Tomatoes June picks.

Clinical: quiet 48 hours. No major new SHM, JAMA Internal Medicine, NEJM, Annals, or AAFP guideline dropped. On the calendar: AAFP's Family Medicine Update livestream (June 16–20) includes a 2026 USPSTF update session — worth a look if you want the year's screening changes in one sitting.

Cuba: nothing materially new in the last 48 hours from mainstream wires beyond the ongoing energy and economic crisis (continued blackouts, fuel and medicine shortages, and the U.S. payment-system squeeze). Background.

Puerto Rico: quiet news cycle. The LUMA-ouster fight continues — the Domenech administration is still saying the operator will be "a thing of the past" this year — but no sharp 48-hour development.

D · Trends to Watch

Pills vs. biologics. Whatever happens with the EPIC Act, industry surveys show companies already steering investment from small-molecule pills toward injected/infused biologics. Over a decade that could mean fewer new oral options — the convenient, cheap-to-administer drugs that matter most for elderly patients you're trying to discharge on a manageable regimen.

Medicare negotiation is becoming routine. CMS is into its third negotiation cycle (initial offers were due June 1), about 9 million beneficiaries are already on negotiated prices, and the first ten drugs fell ~62% on average. Expect drug-cost conversations with your Medicare patients to keep shifting.

E · Ideas & Opportunities

For a post-shift wind-down: the McCartney doc Man on the Run or the final season of Hacks — both short-commitment and well-reviewed.

Golf gear on deck: the HackMotion Sensor 4 wrist-angle analyzer ships June 19 — if your wrist mechanics are the thing you keep fighting, it's worth a demo before you buy.

Mets storyline to follow: Lindor's return in the third week of June. The lineup's been treading water without him; his bat coming back is the swing factor on whether they climb back into the NL East race.